Doyle Wealth Management - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Doyle Wealth Management ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$1,000
-80.0%
2,7800.0%0.00%
-100.0%
Q4 2018$5,0002,7800.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,464,807$14,468,0005.57%
COURAGE CAPITAL MANAGEMENT LLC 192,486$1,130,0000.86%
ESSEX INVESTMENT MANAGEMENT CO LLC 90,455$531,0000.07%
Alambic Investment Management, L.P. 86,204$506,0000.07%
Kalos Management, Inc. 30,000$164,0000.05%
Dynamic Technology Lab Private Ltd 32,394$190,0000.03%
ELLINGTON MANAGEMENT GROUP LLC 60,600$356,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 55,008$323,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$129,0000.02%
ACADIAN ASSET MANAGEMENT LLC 580,972$3,411,0000.02%
View complete list of CONATUS PHARMACEUTICALS INC shareholders